Biologic Augmentation of Temporomandibular Joint Arthroscopy Using Bone Marrow Aspirate Concentrate (BMAC): A Proposed Clinical Trial
Biologic Augmentation of Temporomandibular Joint Arthroscopy Using Bone Marrow Aspirate Concentrate (BMAC): A Proposed Clinical Trial
The goal of this clinical trial is to learn about the efficacy of using Bone Marrow Aspirate Concentrate (BMAC) during temporomandibular joint (TMJ) arthroscopy compared to standard arthroscopic procedures with corticosteroid (CS) injections in patients with pain (arthralgia) of the temporomandibular joint (TMJ) that has failed to respond to conservative treatment. The main question it aims to answer:
Does BMAC injection reduce the amount of inflammation and structural damage in the TMJ? Researchers will compare BMAC injection to corticosteroid injections see if BMAC injection helps .
Participants will :
Inclusion Criteria:
Exclusion Criteria:
Participant has not competed at least 30 days of conservative therapy
Participant was diagnosed with central or neuropathic pain disorder
Participant has a primary diagnosis of myofascial pain
Participant has fibromyalgia
Participant is pregnant or breastfeeding
Participant had traumatic injury to the masticatory muscles or temporomandibular joint within 12 months of screening
Participant who has the following contraindications to MRI:
JOA7035@MED.CORNELL.EDU212.746.5175